Title:
DRUGS CONTAINING AMINOPYRIDINE DERIVATIVES AS THE ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/1998/040356
Kind Code:
A1
Abstract:
Neuropeptide Y receptor antagonists which contain as the active ingredient compounds represented by general formula (I) or salts thereof, wherein Ar represents aryl or heteroaryl; R?1� and R?2� are the same or different and each represents lower alkyl, or R?1� and R?2� may be bonded to each other to form alkylene optionally having intervening oxygen or sulfur; R?3� represents amino, lower alkyl or lower alkylamino; Y represents ethylene, trimethylene, vinylene, propenylene, -O-CH�2?-, -S-CH�2?- or -CH�2?-NH-.
Inventors:
FUKAMI TAKEHIRO (JP)
OKAMOTO OSAMU (JP)
FUKURODA TAKAHIRO (JP)
KANATANI AKIO (JP)
IHARA MASAKI (JP)
OKAMOTO OSAMU (JP)
FUKURODA TAKAHIRO (JP)
KANATANI AKIO (JP)
IHARA MASAKI (JP)
Application Number:
PCT/JP1998/001015
Publication Date:
September 17, 1998
Filing Date:
March 11, 1998
Export Citation:
Assignee:
BANYU PHARMA CO LTD (JP)
FUKAMI TAKEHIRO (JP)
OKAMOTO OSAMU (JP)
FUKURODA TAKAHIRO (JP)
KANATANI AKIO (JP)
IHARA MASAKI (JP)
FUKAMI TAKEHIRO (JP)
OKAMOTO OSAMU (JP)
FUKURODA TAKAHIRO (JP)
KANATANI AKIO (JP)
IHARA MASAKI (JP)
International Classes:
A61K31/44; A61K31/535; A61K31/55; C07D213/74; C07D401/06; C07D401/12; C07D405/06; C07D405/12; C07D413/06; (IPC1-7): C07D213/74; A61K31/44; A61K31/535; A61K31/55; C07D401/06; C07D401/12; C07D405/06; C07D405/12; C07D413/06
Domestic Patent References:
WO1997034873A1 | 1997-09-25 | |||
WO1997025041A1 | 1997-07-17 | |||
WO1997020823A2 | 1997-06-12 | |||
WO1997020821A1 | 1997-06-12 | |||
WO1994000486A1 | 1994-01-06 |
Foreign References:
JPH01131157A | 1989-05-24 |
Attorney, Agent or Firm:
BANYU PHARMACEUTICAL CO., LTD. (Chuo-ku, Tokyo, JP)
BANYU PHARMACEUTICAL CO., LTD. (Chuo-ku, Tokyo, JP)
BANYU PHARMACEUTICAL CO., LTD. (Chuo-ku, Tokyo, JP)
Download PDF:
Previous Patent: PROCESS FOR PREPARING 2-HYDROXY-6-TRIFLUOROMETHYLPYRIDINE
Next Patent: HIV PROTEASE INHIBITORS
Next Patent: HIV PROTEASE INHIBITORS